CytomX
IPODestroy cancer, differently.
Public · South San Francisco, United States · Founded 2008 · $120.0M raised
- Headquarters
- South San Francisco
- Employees
- 51–200
- Founded
- 2008
- Business Model
- B2B
- Total Funding
- $120.0M
- Last Round
- $70.0M Series DJun 2015
- Rounds
- 3
- Type
- Public
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 4 funding rounds and 4 investors for this company. The full record is or through the API.
About
CytomX Therapeutics is a leading clinical-stage biopharmaceutical company in the growing field of conditional activation. The company was founded in 2008 based on technology licensed from the University of California at Santa Barbara (UCSB). CytomX develops Probody therapeutics, with a stated goal of reinventing biologic therapeutics to destroy cancer, differently.
Summary
CytomX is a Biotech company based in South San Francisco, United States, founded in 2008. It has raised $120.0M in total across 3 rounds, most recently a $70.0M Series D round in Jun 2015. Investors include Third Rock Ventures, Pfizer Ventures and Canaan Partners.
Funding & Exit History
Oct 2015
Sign up to see all 4 events
Funding: Series B through Series D. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/cytomx"><img src="https://indexed.vc/api/badge/company/cytomx" alt="CytomX on Indexed.vc" width="260" height="76" /></a>